Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Components and Placebo in COPD (SHINE)
NCT00206154Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of budesonide, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Apr 2005; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00206154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206154.